Michael Thomas Heffernan

Insider Reports History

Location
Cary, NC
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Thomas Heffernan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
COLLEGIUM PHARMACEUTICAL, INC Director Common Stock 50.3K $1.54M $30.52 Feb 10, 2025 Direct
Akebia Therapeutics, Inc. Director Common Stock 48.6K $59.4K $1.22 Jun 2, 2021 Direct
enGene Holdings Inc. Director Stock Option (Right to Buy) 45K Jul 8, 2025 Direct
Trevi Therapeutics, Inc. Director Nonstatutory Stock Option (right to buy) 45K Jun 11, 2025 Direct
Biohaven Ltd. Director Stock Options (Right to buy) 31.7K May 5, 2025 Direct
SYNLOGIC, INC. Director Stock Option (right to buy) 30K Jun 22, 2023 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 29.5K Jun 17, 2025 Direct
Akebia Therapeutics, Inc. Director Stock Option (Right to buy) 20.1K Jun 2, 2021 Direct
Biohaven Pharmaceutical Holding Co Ltd. Director Restricted Share Unit Award 0 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Director Stock Options (Right to Buy) 0 Oct 3, 2022 Direct

Insider Reports Filed by Michael Thomas Heffernan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENGN enGene Holdings Inc. Jul 8, 2025 1 $0 4 Jul 10, 2025 Director
ENGN enGene Holdings Inc. Jul 8, 2025 0 $0 3 Jul 8, 2025 Director
AVTX Avalo Therapeutics, Inc. Jun 17, 2025 1 $0 4 Jun 18, 2025 Director
TRVI Trevi Therapeutics, Inc. Jun 11, 2025 1 $0 4 Jun 13, 2025 Director
BHVN Biohaven Ltd. May 5, 2025 1 $0 4 May 7, 2025 Director
AVTX Avalo Therapeutics, Inc. Mar 25, 2025 1 $0 4 Mar 26, 2025 Director
AVTX Avalo Therapeutics, Inc. Mar 25, 2025 0 $0 3 Mar 26, 2025 Director
COLL COLLEGIUM PHARMACEUTICAL, INC Feb 10, 2025 1 $0 4 Feb 12, 2025 Director
TRVI Trevi Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 16, 2024 1 $0 4 May 16, 2024 Director
BHVN Biohaven Ltd. Apr 30, 2024 1 $0 4 May 2, 2024 Director
TRVI Trevi Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 30, 2023 Director
SYBX SYNLOGIC, INC. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 18, 2023 1 $0 4 May 19, 2023 Director
BHVN Biohaven Ltd. May 2, 2023 1 $0 4 May 4, 2023 Director
COLL COLLEGIUM PHARMACEUTICAL, INC Dec 22, 2022 12 -$186K 4 Dec 27, 2022 Director
COLL COLLEGIUM PHARMACEUTICAL, INC Dec 19, 2022 9 -$583K 4 Dec 21, 2022 Director
COLL COLLEGIUM PHARMACEUTICAL, INC Dec 12, 2022 14 -$1.33M 4 Dec 14, 2022 Director
BHVN Biohaven Ltd. Oct 3, 2022 1 -$72.7K 4/A Oct 12, 2022 Director
BHVN Biohaven Pharmaceutical Holding Co Ltd. Oct 3, 2022 4 $0 4 Oct 3, 2022 Director
BHVN Biohaven Ltd. Sep 28, 2022 0 $0 3 Sep 30, 2022 Director
TRVI Trevi Therapeutics, Inc. Jun 23, 2022 1 $0 4/A Jul 1, 2022 Director
SYBX SYNLOGIC, INC. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 19, 2022 1 $0 4 May 23, 2022 Director
BHVN Biohaven Pharmaceutical Holding Co Ltd. Apr 28, 2022 1 $0 4 Apr 29, 2022 Director
BHVN Biohaven Pharmaceutical Holding Co Ltd. Dec 20, 2021 1 $0 4 Dec 22, 2021 Director
TRVI Trevi Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director
SYBX SYNLOGIC, INC. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
AKBA Akebia Therapeutics, Inc. Jun 2, 2021 2 $0 4 Jun 3, 2021 Director
COLL COLLEGIUM PHARMACEUTICAL, INC May 20, 2021 1 $0 4 May 24, 2021 Director
BHVN Biohaven Pharmaceutical Holding Co Ltd. May 5, 2021 1 $0 4 May 7, 2021 Director